Impact of DNA Damage Response—Targeted Therapies on the Immune Response to Tumours
The DNA damage response (DDR) maintains the stability of a genome faced with genotoxic insults (exogenous or endogenous), and aberrations of the DDR are a hallmark of cancer cells. These cancer-specific DDR defects present new therapeutic opportunities, and different compounds that inhibit key compo...
Main Authors: | Nura Lutfi, Miguel Alejandro Galindo-Campos, José Yélamos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/23/6008 |
Similar Items
-
The multifaceted world of the DNA damage response
by: Antonio ePorro
Published: (2016-05-01) -
Editorial: The impact of the DNA damage response on anti-tumor immunity
by: Gang Chen, et al.
Published: (2022-09-01) -
Advances in DNA damage response inhibitors in colorectal cancer therapy
by: Yu Yue, et al.
Published: (2023-12-01) -
Sumoylation and the DNA Damage Response
by: Xiaolan Zhao, et al.
Published: (2012-09-01) -
Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
by: Alessandra Ferri, et al.
Published: (2020-07-01)